113 related articles for article (PubMed ID: 1903028)
1. Neuroblastoma screening: arguments from retrospective analysis of three German neuroblastoma trials.
Berthold F; Hunneman DH; Käser H; Harms D; Bertram U; Erttmann R; Schilling FH; Treuner J; Zieschang J
Am J Pediatr Hematol Oncol; 1991; 13(1):8-13. PubMed ID: 1903028
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study.
Hiyama E; Iehara T; Sugimoto T; Fukuzawa M; Hayashi Y; Sasaki F; Sugiyama M; Kondo S; Yoneda A; Yamaoka H; Tajiri T; Akazawa K; Ohtaki M
Lancet; 2008 Apr; 371(9619):1173-80. PubMed ID: 18395578
[TBL] [Abstract][Full Text] [Related]
3. Screening for neuroblastoma: a resurrected idea?
Maris JM; Woods WG
Lancet; 2008 Apr; 371(9619):1142-3. PubMed ID: 18395561
[No Abstract] [Full Text] [Related]
4. [Comprehensive protocol for diagnosis and treatment of childhood neuroblastoma--results of 45 cases].
Tang JY; Pan C; Chen J; Xu M; Chen J; Xue HL; Gu LJ; Dong R; Ye H; Zhou M; Wang YP
Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):770-3. PubMed ID: 17229383
[TBL] [Abstract][Full Text] [Related]
5. Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany.
Schilling FH; Spix C; Berthold F; Erttmann R; Sander J; Treuner J; Michaelis J
Cancer Lett; 2003 Jul; 197(1-2):19-28. PubMed ID: 12880955
[TBL] [Abstract][Full Text] [Related]
6. Neuroblastoma: epidemiology and pattern of regression. Problems in interpreting results of mass screening.
Carlsen NL
Am J Pediatr Hematol Oncol; 1992 May; 14(2):103-10. PubMed ID: 1530115
[TBL] [Abstract][Full Text] [Related]
7. [Limitations in the histopathologic diagnosis and prognosis of neuroblastoma].
Mihăilă D; Aprodu G; Ionescu C; Miron I; Maxim E; Plămădeală P
Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):834-40. PubMed ID: 14756030
[TBL] [Abstract][Full Text] [Related]
8. The recurrence patterns of stages I, II and III neuroblastoma: experience with 77 relapsing patients.
Berthold F; Hero B; Breu H; Christiansen H; Erttmann R; Gnekow A; Herrmann F; Klingebiel T; Lampert F; Müller-Weihrich S; Weinel P
Ann Oncol; 1996 Feb; 7(2):183-7. PubMed ID: 8777176
[TBL] [Abstract][Full Text] [Related]
9. Long-term survival of children with neuroblastoma prior to the neuroblastoma screening project in Germany.
Burkhardt-Hammer T; Spix C; Brenner H; Kaatsch P; Berthold F; Hero B; Michaelis J
Med Pediatr Oncol; 2002 Sep; 39(3):156-62. PubMed ID: 12210443
[TBL] [Abstract][Full Text] [Related]
10. Neuroblastoma in adolescents: the Italian experience.
Conte M; Parodi S; De Bernardi B; Milanaccio C; Mazzocco K; Angelini P; Viscardi E; Di Cataldo A; Luksch R; Haupt R
Cancer; 2006 Mar; 106(6):1409-17. PubMed ID: 16475209
[TBL] [Abstract][Full Text] [Related]
11. [Hepatopathy in patients with stage 4S neuroblastoma].
Claviez A; Hero B; Schneppenheim R; Berthold F
Klin Padiatr; 1996; 208(4):221-8. PubMed ID: 8926687
[TBL] [Abstract][Full Text] [Related]
12. Mass screening of neuroblastoma in Sapporo City, Japan.
Nishi M; Miyake H; Takeda T; Kikuchi Y; Hanai J; Yonemori H; Takasugi N
Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):327-31. PubMed ID: 1456398
[TBL] [Abstract][Full Text] [Related]
13. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
[TBL] [Abstract][Full Text] [Related]
14. Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma.
Spitz R; Hero B; Simon T; Berthold F
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3368-73. PubMed ID: 16740759
[TBL] [Abstract][Full Text] [Related]
15. A population-based study of the usefulness of screening for neuroblastoma.
Woods WG; Tuchman M; Robison LL; Bernstein M; Leclerc JM; Brisson LC; Brossard J; Hill G; Shuster J; Luepker R; Byrne T; Weitzman S; Bunin G; Lemieux B
Lancet; 1996 Dec 21-28; 348(9043):1682-7. PubMed ID: 8973429
[TBL] [Abstract][Full Text] [Related]
16. Neuroblastoma Screening at 1 Year of Age: The Final Results of a Controlled Trial.
Berthold F; Spix C; Erttmann R; Hero B; Michaelis J; Treuner J; Ernst A; Schilling FH
JNCI Cancer Spectr; 2021 Jul; 5(4):. PubMed ID: 34240006
[TBL] [Abstract][Full Text] [Related]
17. Poor prognosis neuroblastoma: is screening the answer?
Craft AW; Parker L
Br J Cancer Suppl; 1992 Aug; 18():S96-101. PubMed ID: 1503935
[TBL] [Abstract][Full Text] [Related]
18. Neuroblastoma.
Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
[TBL] [Abstract][Full Text] [Related]
19. [Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study].
Ladenstein R; Ambros PF; Urban C; Ambros IM; Fink FM; Zoubek A; Grienberger H; Schmitt K; Kerbl R; Horcher E; Amann G; Höfler G; Heinzl H; Gadner H; Mutz I
Klin Padiatr; 1996; 208(4):210-20. PubMed ID: 8926686
[TBL] [Abstract][Full Text] [Related]
20. [Neurologic symptoms in the course of neuroblastoma in children. Own observations].
Połczyńska K; Bień E; Stefanowicz J; Drozyńska E; Szołkiewicz A; Stachowicz-Stencel T; Sierota D; Kaczorowska-Hać B; Kosiak W; Balcerska A
Med Wieku Rozwoj; 2005; 9(3 Pt 2):477-86. PubMed ID: 16719160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]